Preventive blood thinning drugs linked to reduced risk of death in covid-19 patients

▴ Preventive blood thinning drugs linked to reduced risk of death in covid-19 patients
Strong evidence that prompt anti-clotting therapy may prevent deaths in hospital patients

Patients given preventive blood thinning drugs (prophylactic anticoagulants) within 24 hours of admission to hospital with covid-19 are less likely to die compared with those who do not receive them, finds a study published by The BMJ today.

Clinical trials are now underway to see if prophylactic anticoagulants could be an effective treatment for covid-19. In the meantime, the researchers say these findings provide strong real world evidence to support their early use among patients in hospital with covid-19.

Some covid deaths are believed to be due to blood clots developing in major veins and arteries. Anticoagulants prevent blood clots forming and have antiviral and potentially anti-inflammatory properties, so might be particularly effective in patients with covid-19, but results from previous studies have been inconclusive.

To explore this further, a team of UK and US researchers set out to estimate the effect of prophylactic anticoagulants when given promptly after admission to hospital on risk of death and severe bleeding among patients with covid-19.

Their findings are based on data from the United States Department of Veterans Affairs for 4,297 patients (average age 68 years; 93% men) admitted to hospital with covid-19 between 1 March and 31 July 2020.

Other potentially important factors including age, ethnicity, underlying conditions, medication history, weight, and smoking status were taken into account. The researchers then followed these patients to see who died or experienced a serious bleeding event within 30 days of hospital admission.

A total of 3,627 (84.4%) of patients received prophylactic anticoagulation within 24 hours of admission and there were 622 deaths (14.5%) within 30 days.

Death at 30 days was 14.3% among those who received prophylactic anticoagulation compared with 18.7% among those who did not - a relative risk reduction as high as 34% and an absolute risk reduction of 4.4%.

This benefit seemed to be greater among patients not admitted to the intensive care unit (ICU) within 24 hours of hospital admission.

Receiving prophylactic anticoagulation was not associated with an increased risk of serious bleeding.

This was a large, well-designed study using electronic health record data and took account of a range of potentially influential factors. Results were also unchanged after further analyses, suggesting that they withstand scrutiny.

However, the researchers acknowledge that due to the observational nature of the study, a degree of uncertainty persists that can only be addressed through randomised trials.

Until further trial evidence is available, they conclude that these findings “provide strong real world evidence to support guidelines recommending the use of prophylactic anticoagulation as initial treatment for patients with covid-19 on hospital admission.”

Tags : #BloodThinningDrugs #TheBMJ #BloodThinningDrugsCOVID-19 #LatestResearchonCOVID-19 #LatestPharmaResearch12thFeb #LatestPharmaNews12thFeb #COVIDDeaths

About the Author


Team Medicircle

Related Stories

Loading Please wait...
-Advertisements-


Trending Now

Are You Struggling with “Maskne”? Find the Top 5 Solutions to deal with it. March 03, 2021
Exercise could well mimic the effects of Polypill , also it's cheaper and without side effectsMarch 03, 2021
Sorrento receives USFDA clearance to start a clinical trial of Anti-CD47 antibodyMarch 03, 2021
Regular breast checks by trained health workers linked to fewer breast cancer deaths in IndiaMarch 03, 2021
Treat Doctors as Friends and Have an Open Chat with Them says Dr. Shailaja Sabnis, Consultant Physician and Rheumatologist March 03, 2021
PM Jan Aushadhi Kendra inaugurated at District Hospital, KargilMarch 02, 2021
Maharashtra records 6,397 new cases of coronavirus todayMarch 02, 2021
One in four people will have hearing problems by 2050: WHOMarch 02, 2021
6 states show surge in Covid-19 cases, India's total active cases reach 1,68,627March 02, 2021
hday for longer life ; American Heart AssociationMarch 02, 2021
Is your baby cranky due to skin complaints? Here are some quick solutions that can help you.March 02, 2021
Women Have the Right to Say “No”, says Dr. Vaishali Joshi, Senior Obstetrician & Gynaecologist, Kokilaben Ambani Hospital, MumbaiMarch 02, 2021
How to Control STDs, explains, Dr. Nikul Patel, Founder and Chief Ayurveda Consultant of Atharva Ayurveda Clinic and Panchakarma Center March 02, 2021
Registration for next phase of COVID19 Vaccination on Co-WIN2.0 portal will open at 9:00 am on 1st MarchMarch 01, 2021
Union Minister Dr. Harsh Vardhan inaugurated major healthcare projects in Imphal yesterdayMarch 01, 2021
AMRI joins network of approved manufacturers of Lipid Excipients for Pfizer-BioNTech COVID-19 VaccineMarch 01, 2021
Nationwide COVID-19 vaccination drive to cover senior citizens & people with comorbidities begins todayMarch 01, 2021
Johnson & Johnson's Covid-19 vaccine gets emergency use authorization from FDAMarch 01, 2021
“Living with Rheumatoid Arthritis” - Myth Debunked by the Expert Rheumatologist, Dr. Naga PrabhuMarch 01, 2021
Good Sexual Health is Extremely Important for Overall Health of an Individual, says Dr. Vilvapathy Karthikeyan, Consultant AndrologistMarch 01, 2021